Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 12 min ago
Peer-reviewedCC BYJournal for immunotherapy of cancer

Neuroimmune crosstalk in cancer: emerging immunotherapeutic opportunities.

  • Tianhui Dong1
  • Hidde Ploeger2
  • Tuany Eichwald1,3
  • Laura Brabenec3
  • Moutih Rafei4
  • Moran Amit5
  • Alessandra Gargano6
  • Sebastien Talbot7,3
7 affiliations
  1. 1Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada.
  2. 2TRON-Translational Oncology at the University Medical Cente, Johannes Gutenberg University Mainz, Mainz, Germany.
  3. 3Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
  4. 4Département de Pharmacologie et Physiologie, Université de Montréal, Montreal, Québec, Canada.
  5. 5Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  6. 6TRON-Translational Oncology, Johannes Gutenberg University Mainz, Mainz, Germany.
  7. 7Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada [email protected].
Read full textPDFDOICite

Related

  1. The obesity–neuroinflammation–cancer axis: neuroimmune remodeling and therapeutic opportunities
    Nan Yang, Wei Zhang, Yinsheng Zhong +1
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textPsychiatry & mental healthCrossref
  2. Post-Translational Modification Crosstalk in Gastric Cancer: Molecular Switches, Signaling Networks, and Therapeutic Opportunities, with Comparative Insights from Colorectal Cancer
    Jun Wang, Xianying Chen, Yu Wang +1
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  3. Targeting the PSGL-1 glycoprotein in cancer: cellular mechanisms and emerging immunotherapeutic strategies.
    João L Pereira, Nuno R Dos Santos
    Immunotherapy advancesPeer-reviewedCC BY-NCFull textOncologyEurope PMC
  4. Dodonaea viscosa in Breast Cancer: Phytochemistry, Anticancer Mechanisms, and Emerging Immunotherapeutic and Translational Perspectives
    Nireshini Reddy, Catherine H. Kaschula, Nokwanda P. Makunga +3
    Cancer MedicinePeer-reviewedCC BYFull textPharmacology & toxicologyDOAJ
  5. The neuro–metabolic–immune axis in breast cancer: emerging mechanisms and subtype-specific therapeutic opportunities
    Nannan Xia, Renhong Huang, Hanyi Zhong +4
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textPsychiatry & mental healthCrossrefEurope PMCPMCEurope PMC

Cite

BibTeXRIS
BibTeX
@article{dong2026neuroimmune,
  title = {{Neuroimmune crosstalk in cancer: emerging immunotherapeutic opportunities.}},
  author = {Tianhui Dong and Hidde Ploeger and Tuany Eichwald and Laura Brabenec and Moutih Rafei and Moran Amit and Alessandra Gargano and Sebastien Talbot},
  journal = {Journal for immunotherapy of cancer},
  year = {2026},
  month = oct,
  doi = {10.1136/jitc-2026-015675},
  url = {https://europepmc.org/article/MED/42906945},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Neuroimmune crosstalk in cancer: emerging immunotherapeutic opportunities.
AU  - Tianhui Dong
AU  - Hidde Ploeger
AU  - Tuany Eichwald
AU  - Laura Brabenec
AU  - Moutih Rafei
AU  - Moran Amit
AU  - Alessandra Gargano
AU  - Sebastien Talbot
PY  - 2026
DA  - 2026/10/21
JO  - Journal for immunotherapy of cancer
DO  - 10.1136/jitc-2026-015675
UR  - https://europepmc.org/article/MED/42906945
SN  - 2051-1426
ER  -